Definium Therapeutics Inc. Common Shares vs Principal Financial Group Inc Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.9 (market cap $4.59B), while Principal Financial Group Inc Common Stock trades at $107.24 (market cap $23.51B). The key difference: Principal Financial Group Inc Common Stock is far larger — about 5.1× Definium Therapeutics Inc. Common Shares's market cap, and Principal Financial Group Inc Common Stock pays a 3.06% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Principal Financial Group Inc Common Stock for 1 Days on average.
| DFTX | PFG | |
|---|---|---|
Market Cap | $4.59B | $23.51B |
Volume | 2,103,937 | 1,118,505 |
Sector | Health | Financials |
52-Week High | $48.45 | $118.51 |
52-Week Low | $10.68 | $78.39 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $3.55B | $22.59B |
Dividend Yield | — | 3.06% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Principal Financial Group provides retirement, insurance, and asset management services. It serves individuals, employers, and institutional clients.
Read more on PFG →